HC quashes Centre’s ban on oxytocin manufacture

Government had barred private firms

Updated - December 03, 2021 10:04 am IST

Published - December 14, 2018 10:30 pm IST - New Delhi

The Delhi High Court on Friday quashed the Centre’s decision to ban the manufacture and sale of Oxytocin, a drug which induces labour and controls bleeding during child birth, by private firms.

A Bench of Justices S. Ravindra Bhat and A.K. Chawla set aside the government’s April 27 notification imposing the ban, saying it was “arbitrary and unreasonable”.

“The UoI did not adequately weigh in the danger to the users of Oxytocin, nor consider the deleterious effect to the public generally and women particularly, of possible restricted supply if manufacture is confined to one unit, to the pregnant women and young mothers, of a potentially life-saving drug,” the Bench said. It said the Centre’s decision to allow only a single, state-run entity — with no prior experience in manufacturing Oxytocin — to make and sell the drug, was “fraught with potential adverse consequences”. “The risk of such a consequence can be drastic: the scarcity of the drug, or even a restricted availability can cause increase in maternal fatalities, during childbirth, impairing lives of thousands of innocent young mothers,” it said.

The Bench was not impressed with the Centre’s “far greater” reliance on the need to prohibit availability of Oxytocin from what was perceived to be widespread veterinary misuse. “Correspondingly there was no scientific basis, and insufficient data to support the conclusion that the drug’s existing availability or manner of distribution posed a risk to human life,” it added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.